MTAC — MedTech Acquisition Balance Sheet
0.000.00%
Last trade - 00:00FinancialsBalancedSmall CapNeutral
- $83.67m
- $84.86m
- 42
- 11
- 57
- 29
Annual balance sheet for MedTech Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | 10-K/A | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 1.33 | 0.201 | 0.154 |
| Prepaid Expenses | |||
| Total Current Assets | 2.01 | 0.526 | 0.36 |
| Other Long Term Assets | |||
| Total Assets | 252 | 251 | 20.2 |
| Payable / Accrued | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.103 | 1.6 | 2.5 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 23.5 | 17.3 | 13.7 |
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 229 | 233 | 6.53 |
| Total Liabilities & Shareholders' Equity | 252 | 251 | 20.2 |
| Total Common Shares Outstanding |